Benzinga | Nov 9, 2021 06:06PM EST

Cormedix Q3 EPS $(0.22) Misses $(0.18) Estimate, Sales $38.09K Beat $20.00K Estimate

Cormedix (AMEX:CRMD) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.18) by 22.22 percent. This is unchanged from the same period last year. The company reported quarterly sales of $38.09 thousand which beat the analyst consensus estimate of $20.00 thousand by 90.44 percent. This is a 59.05 percent decrease over sales of $93.02 thousand the same period last year.